BONE BIOLOGICS CORP (BBLG) Earnings History & Surprises
NASDAQ:BBLG • US0980706008
1.24 USD
+0.02 (+1.64%)
Last: Mar 6, 2026, 04:00 PM
Past quarterly earnings results for BONE BIOLOGICS CORP (BBLG), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMay 11, 2026
Last Reported
Release DateMar 2, 2026
PeriodQ4 / 2025
EPS Reported-$0.14
EPS Surprise 59.63%
Revenue Surprise %
Beat Rate
38%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.14 | -0.35 | 59.63% | 96.20% | - | - | ||
| Q3 2025 | -0.37 | -1.25 | 70.51% | 97.40% | - | - | ||
| Q2 2025 | -1.33 | -0.59 | -124.81% | 66.92% | - | - | ||
| Q1 2025 | -1.92 | -2.94 | 34.64% | 75.57% | - | - | ||
| Q4 2024 | -3.68 | -3.98 | 7.39% | 75.14% | - | - | ||
| Q3 2024 | -14.22 | -3.67 | -287.25% | 51.43% | - | - | ||
| Q2 2024 | -4.02 | -8.51 | 52.74% | 82.55% | - | - | ||
| Q1 2024 | -7.86 | -46.51 | 83.10% | 97.63% | - | - | ||
| Q4 2023 | -14.82 | -34.27 | 56.76% | 94.28% | - | - | ||
| Q3 2023 | -29.28 | -148.84 | 80.33% | 83.06% | - | - | ||
| Q2 2023 | -23.04 | -73.44 | 68.63% | 68.00% | - | - | ||
| Q1 2023 | -331.20 | -102.82 | -222.13% | -228.57% | - | - | ||
| Q4 2022 | -259.20 | -330.48 | 21.57% | -3.81% | - | - | ||
| Q3 2022 | -172.80 | -220.32 | 21.57% | -101,547.06% | - | - | ||
| Q2 2022 | -72.00 | -176.26 | 59.15% | - | - | - | ||
| Q1 2022 | -100.80 | -293.76 | 65.69% | - | - | - | ||
| Q4 2021 | -249.70 | - | - | - | - | |||
| Q3 2021 | -0.17 | - | - | - | - | |||
| Q2 2021 | - | - | - | - | ||||
| Q1 2021 | - | - | - | - | ||||
| Q4 2020 | - | - | - | - | ||||
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - | ||||
| Q1 2020 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
9.99%
Max EPS beat (4)
70.51%
Min EPS beat (4)
-124.81%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, BBLG has beaten EPS estimates in 3 out of 4 releases
In the last 4 quarters, BBLG has beaten the EPS estimates by 10.0% on average.
BONE BIOLOGICS CORP / BBLG Earnings FAQ
Can you provide the last earnings date for BONE BIOLOGICS CORP?
BONE BIOLOGICS CORP (BBLG) last reported earnings on 3/2/2026.
Can you provide information on whether BONE BIOLOGICS CORP beat earnings estimates in the last quarter?
BONE BIOLOGICS CORP (BBLG) beat EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does BBLG stock beat earnings estimates?
In the last 4 quarters, BONE BIOLOGICS CORP (BBLG) has beaten EPS estimates in 3 out of 4 releases.